Accounting for proximal variants improves neoantigen prediction

Keyphrases

• Binding Prediction 16%
• False Discovery Rate 16%
• False Negative Rate 16%
• Germline Alterations 16%
• MHC Class II 16%
• Missense 33%
• Neoantigen 100%
• Neoantigen Prediction 100%
• Peptide Sequencing 33%
• Personalized Cancer Therapy 16%
• Prediction Strategy 16%
• Somatic Alterations 16%
• Somatic Variants 50%
• Stronger Binding 16%
• Tumor 16%

Biochemistry, Genetics and Molecular Biology

• Cancer Immunotherapy 50%
• Germ Cell 50%
• Germline 50%
• Major Histocompatibility Complex 50%
• Missense 100%
• Peptide Sequence 100%

Immunology and Microbiology

• Amino Acid Sequence 25%
• Cancer Immunotherapy 12%
• Germ Cell 12%
• Major Histocompatibility Complex 12%
• Neoantigen 100%